A Curated Platform of Equity & Options Market Intelligence
Select Page

MGNX

Search by
TICKER SYMBOL

Macrogenics Inc

Sector: Manufacturing
Industry: Pharmaceutical Products

1.48

-0.08

(-5.13%)

Volume:

949,922

52 week range:

1.46 - 19.54

Market Cap:

93.374M

Company Description:

MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer. The company also develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4.